EVOLUTION Life Science Partners is an investment bank focused on the needs of life sciences and healthcare companies.
We assist companies throughout their life cycle, including capital raising, licensing/partnering, and M&A. Our work covers the large pharma, biotechnology, medical device, and molecular diagnostic sectors. The firm was formed in 2014 by experienced investment bankers, formerly with firms such as Lehman Brothers, Bear Stearns, Eli Lilly, GlaxoSmithKline, Bain & Company, and Burrill Securities. Our chairman, Fred Frank, is considered to be the first life sciences specialist in investment banking. He founded the biotechnology practice at Lehman Brothers. The senior bankers at EVOLUTION have an average of 25 years of investment banking and industry experience, executing hundreds of M&A, partnering, and capital raising engagements, with an aggregate deal value in excess of $125 billion.